SCHEMBL715384

SCHEMBL715384

CO[C@@H](CO)[C@H](O)COP(=O)(O)O

nearest known ligand 0.66

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PGD P52209 3/20 0.48
MPI P34949 1/20 0.48
PGK1 P00558 1/20 0.42
PGK2 P07205 1/20 0.42
LPAR5 Q9H1C0 1/20 0.40
ENPP2 Q13822 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27622621 1.00 PGD (0.48) PGDMPIPGK1PGK2LPAR5
SCHEMBL7879367 0.86 BTN3A1 (0.42) PGDMPI
SCHEMBL6837508 0.85 PGD (0.44) PGDMPIPGK1PGK2LPAR5
SCHEMBL15270851 0.82 PGD (0.50) PGDMPIPGK1PGK2LPAR5
E968 SCHEMBL18341349 0.77 PGD (0.57) PGDMPIPGK1PGK2LPAR5
SCHEMBL5081076 0.77 PGD (0.57) PGDMPIPGK1PGK2LPAR5
SCHEMBL20455444 0.77 PGD (0.57) PGDMPIPGK1PGK2LPAR5
SCHEMBL14941155 0.77 PGD (0.57) PGDMPIPGK1PGK2LPAR5
E968 SCHEMBL18341348 0.77 PGD (0.57) PGDMPIPGK1PGK2LPAR5
SCHEMBL18341438 0.77 PGD (0.57) PGDMPIPGK1PGK2LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117940155-A Immunogenic composition, preparation method and application thereof 清华大学 2024-04-26 CN claimed
US-9637766-B2 Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-05-02 US claimed
US-20160298153-A1 Host Cells and Methods for Producing 1-Deoxyxylulose 5-phosphate (DXP) and/or a DXP Derived Compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-10-13 US claimed
US-9382553-B2 Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-07-05 US claimed
WO-2013133772-A1 AN INTEGRATED SOLID PHASE EXTRACTION COUPLED ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (SPE-UPLC-MS) METHOD FOR THE PROFILING OF DXP METABOLITES AND SYSTEM DIAGNOSTICS OF DXP PATHWAY NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-09-12 WO claimed
US-20130052692-A1 Host Cells and Methods for Producing 1-Deoxyxylulose 5-phosphate (DXP) and/or a DXP Derived Compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-02-28 US claimed
WO-2011005756-A1 DELIVERY OF AGENTS TARGETED TO MICROBIOTA NICHES PURETECH VENTURES, LLC (US) 2011-01-13 WO claimed
US-20080318227-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway BACHER ADELBERT 2008-12-25 US claimed
EP-1895008-A2 Isoprenoid biosynthesis Bacher, Adelbert (DE) 2008-03-05 EP claimed
EP-1198575-B1 ISOPRENOID BIOSYNTHESIS BACHER ADELBERT (DE) 2007-09-19 EP claimed
US-7122331-B1 Isoprenoid biosynthesis EISENREICH WOLFGANG 2006-10-17 US claimed
US-20040176570-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway ROHDICH, FELIX (DE) 2004-09-09 US claimed
WO-2004072276-A1 CRYSTAL STRUCTURE OF 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE SYNTHASE IN COMPLEX WITH INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2004-08-26 WO claimed
EP-1377663-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY Bacher, Adelbert (DE) 2004-01-07 EP claimed
WO-2002083720-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2002-10-24 WO claimed
EP-1198575-A1 ISOPRENOID BIOSYNTHESIS Bacher, Adelbert (DE) 2002-04-24 EP claimed
EP-1141379-A1 SCREENING FOR INHIBITORS OF TERPENOIDS BIOSYNTHESIS Bacher, Adelbert (DE) 2001-10-10 EP claimed
WO-2001011055-A1 ISOPRENOID BIOSYNTHESIS BACHER ADELBERT (DE) 2001-02-15 WO claimed
WO-2000036138-A1 SCREENING FOR INHIBITORS OF TERPENOIDS BIOSYNTHESIS BACHER ADELBERT (DE) 2000-06-22 WO claimed
CN-118703543-A Ser126 as key amino acid site of YFT3 protein for controlling tomato fruit color formation and application thereof in tomato quality improvement 上海交通大学 2024-09-27 CN disclosed
CN-112771169-B Method for recovering water-immiscible isoprenoid compounds from microbial biomass 阿迈瑞斯公司 2024-07-09 CN disclosed
US-20240218403-A1 BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF GINKGO BIOWORKS, INC. (US) 2024-07-04 US disclosed
US-20240191053-A1 SYSTEMS, MICROORGANISMS, OR METHODS FOR WASTE PET VALORIZATION WASHINGTON UNIVERSITY (US) 2024-06-13 US disclosed
WO-2024092150-A2 COMBINATION THERAPIES UTILIZING MICROBIALLY-EXPANDED GAMMA DELTA T CELLS AND T CELL ENGAGING BIOLOGICS PROVIDENCE HEALTH & SERVICES - OREGON (US) 2024-05-02 WO disclosed
CN-117940155-A Immunogenic composition, preparation method and application thereof 清华大学 2024-04-26 CN disclosed
EP-4314271-A1 BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF Ginkgo Bioworks, Inc. (US) 2024-02-07 EP disclosed
CN-117460825-A Biosynthesis of isoprenoids and their precursors 银杏生物制品公司 2024-01-26 CN disclosed
WO-2023133490-A1 SKIN COMMENSAL BACTERIA ENGINEERED TO PRODUCE TERPENES GINKGO BIOWORKS, INC. (US) 2023-07-13 WO disclosed
CN-114507679-B Pinus massoniana terpenoid synthesis related enzyme gene PmDXR and application of promoter thereof 南京林业大学 2023-06-30 CN disclosed
CN-115295073-A Method for mining terpenoid synthesis key genes of pepper leaves based on third-generation full-length transcriptome and second-generation transcriptome sequencing 长江大学 2022-11-04 CN disclosed
WO-2022221338-A2 SYSTEMS, MICROORGANISMS, OR METHODS FOR WASTE PET VALORIZATION WASHINGTON UNIVERSITY (US) 2022-10-20 WO disclosed
WO-2022212917-A1 BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF GINKGO BIOWORKS, INC. (US) 2022-10-06 WO disclosed
CN-114507679-A Pinus massoniana terpenoid substance synthesis related enzyme gene PmDXR and application of promoter thereof 南京林业大学 2022-05-17 CN disclosed
CN-108138167-B Method for preparing linalool 味之素株式会社 2022-05-17 CN disclosed
US-20220119823-A1 Univariant Extrinsic Initiator Control System For Microbes And An In Vitro Assembly Of Large Recombinant DNA Molecules From Multiple Components MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2022-04-21 US disclosed
EP-3703756-B1 USE OF STATINS IN OVERCOMING RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN BACTERIAL SPECIES SYNTHETIZING ISOPRENOIDS USING THE MEVALONATE SYNTHETIC PATHWAY CONSEJO SUPERIOR INVESTIGACION (ES) 2022-04-20 EP disclosed
CN-108138168-B Linalool composition and preparation method thereof 味之素株式会社 2022-04-05 CN disclosed
US-11180764-B2 Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components NATIONAL UNIVERSITY OF SINGAPORE (SG) 2021-11-23 US disclosed
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents NORTHERN ILLINOIS RESEARCH FOUNDATION (US) 2021-06-08 US disclosed
CN-112771169-A Method for recovering water-immiscible isoprenoid compounds from microbial biomass 阿迈瑞斯公司 2021-05-07 CN disclosed
US-20200345701-A1 USE OF STATINS IN OVERCOMING RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN BACTERIAL SPECIES SYNTHETIZING ISOPRENOIDS USING THE MEVALONATE SYNTHETIC PATHWAY CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2020-11-05 US disclosed
US-10772900-B2 Drug target for treating veterinary infections and methods of using same THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2020-09-15 US disclosed
EP-3703756-A1 USE OF STATINS IN OVERCOMING RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN BACTERIAL SPECIES SYNTHETIZING ISOPRENOIDS USING THE MEVALONATE SYNTHETIC PATHWAY Consejo Superior de Investigaciones Cientificas (CSIC) (ES) 2020-09-09 EP disclosed
US-20190330642-A1 Univariant Extrinsic Initiator Control System For Microbes And An In Vitro Assembly Of Large Recombinant DNA Molecules From Multiple Components NATIONAL UNIVERSITY OF SINGAPORE (SG) 2019-10-31 US disclosed
US-20190282592-A1 Drug Target For Treating Veterinary Infections And Methods Of Using Same UNIV PENNSYLVANIA (US) 2019-09-19 US disclosed
CN-105267203-B A kind of 1-Deoxy-D-xylulose 5-phosphate reductive isomerase inhibitor 西北大学 2019-05-03 CN disclosed
CN-109342634-A A kind of method of column front derivation-HPLC measurement DXS enzymatic activity 西北大学 2019-02-15 CN disclosed
US-20180271098-A1 OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-09-27 US disclosed
US-20180110795-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PERIODONTAL DISEASE THE FORSYTH INSTITUTE (US) 2018-04-26 US disclosed
US-20170136030-A1 TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY WASHINGTON UNIVERSITY (US) 2017-05-18 US disclosed
US-9637766-B2 Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-05-02 US disclosed
CN-106190995-A (E) 4 hydroxyl 3 methyl 2 cyclobutenyl diphosphate synthase and encoding gene thereof and application 西安电子科技大学 2016-12-07 CN disclosed
US-20160298153-A1 Host Cells and Methods for Producing 1-Deoxyxylulose 5-phosphate (DXP) and/or a DXP Derived Compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-10-13 US disclosed
CN-106011090-A Reductase and encoding gene and application thereof 西安电子科技大学 2016-10-12 CN disclosed
US-9382553-B2 Host cells and methods for producing 1-deoxyxylulose 5-phosphate (DXP) and/or a DXP derived compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-07-05 US disclosed
US-20160046651-A1 TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY UNIV WASHINGTON (US) 2016-02-18 US disclosed
US-20150284729-A1 Univariant Extrinsic Initiator Control System for Microbes and an In Vitro Assembly of Large Recombinant DNA Molecules From Multiple Components MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2015-10-08 US disclosed
WO-2014077782-A1 UNIVARIANT EXTRINSIC INITIATOR CONTROL SYSTEM FOR MICROBES AND AN IN VITRO ASSEMBLY OF LARGE RECOMBINANT DNA MOLECULES FROM MULTIPLE COMPONENTS NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-05-22 WO disclosed
WO-2013133772-A1 AN INTEGRATED SOLID PHASE EXTRACTION COUPLED ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (SPE-UPLC-MS) METHOD FOR THE PROFILING OF DXP METABOLITES AND SYSTEM DIAGNOSTICS OF DXP PATHWAY NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-09-12 WO disclosed
US-20130130345-A1 PRODUCTION OF RENEWABLE AROMATIC COMPOUNDS JNF BIOCHEMICALS, LLC (US) 2013-05-23 US disclosed
WO-2013036100-A1 A METHOD FOR REGULATING PLASTIDIAL ISOPRENOID BIOSYNTHESIS IN HEVEA BRASILIENSIS UNIVERSITI SAINS MALAYSIA (MY) 2013-03-14 WO disclosed
US-20130052692-A1 Host Cells and Methods for Producing 1-Deoxyxylulose 5-phosphate (DXP) and/or a DXP Derived Compound THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-02-28 US disclosed
US-20120052535-A1 PRODUCTION OF TERPENES AND TERPENOIDS IN GLANDULAR TRICHOME-BEARING PLANTS WASHINGTON STATE UNIVERSITY 2012-03-01 US disclosed
WO-2012006039-A2 PRODUCTION OF RENEWABLE AROMATIC COMPOUNDS JNF BIOCHEMICALS, LLC (US) 2012-01-12 WO disclosed
WO-2010111571-A1 PRODUCTION OF TERPENESE AND TERPENOIDS IN GLANDULAR TRICHOME-BEARING PLANTS WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-09-30 WO disclosed
US-20100172874-A1 GUT MICROBIOME AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR AN OBESITY RELATED DISORDER THE WASHINGTON UNIVERSITY (US) 2010-07-08 US disclosed
US-7736881-B2 Genome with a disruption in a first gene in the endogenous methylerythritol phosphate (MEP) pathway; transgenic mevalonic acid (MVA) mini operon UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2010-06-15 US disclosed
EP-2102350-A2 THE GUT MICROBIOME AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR AN OBESITY RELATED DISORDER Washington University in St. Louis (US) 2009-09-23 EP disclosed
US-20090226986-A1 Production of Coenzyme Q-10 BERRY ALAN 2009-09-10 US disclosed
US-7572609-B2 Production of isoprenoids DSM IP ASSETS B.V. (NL) 2009-08-11 US disclosed
US-20090199313-A1 Non-mevalonate isoprenoid pathway BACHER ADELBERT 2009-08-06 US disclosed
US-7534742-B2 Isoprenoid biosynthesis EISENREICH WOLFGANG 2009-05-19 US disclosed
US-20080318227-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway BACHER ADELBERT 2008-12-25 US disclosed
EP-1287145-B1 THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2008-11-26 EP disclosed
EP-1641931-B1 IMPROVED PRODUCTION OF COENZYME Q-10 DSM IP ASSETS BV (NL) 2008-11-19 EP disclosed
WO-2008076696-A2 THE GUT MICROBIOME AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR AN OBESITY RELATED DISORDER WASHINGTON UNIVERSITY IN ST. LOUIS (US) 2008-06-26 WO disclosed
EP-1895008-A2 Isoprenoid biosynthesis Bacher, Adelbert (DE) 2008-03-05 EP disclosed
US-20070269857-A1 A PROCESS FOR PRODUCING ISOPRENOID COMPOUNDS BY MICROORGANISMS AND A METHOD FOR SCREENING COMPOUNDS WITH ANTIBIOTIC OR WEEDING ACTIVITY KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-11-22 US disclosed
US-7297509-B2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway Bacher, Adelbert (DE) 2007-11-20 US disclosed
US-7288367-B2 Used for a screening method for inhibitors of enzymes of the pathway, and a method for identifying inhibitor-resistant variants BACHER ADELBERT 2007-10-30 US disclosed
EP-1198575-B1 ISOPRENOID BIOSYNTHESIS BACHER ADELBERT (DE) 2007-09-19 EP disclosed
US-20070202579-A1 Production Of Isoprenoids DSM IP ASSETS B.V. (NL) 2007-08-30 US disclosed
US-20070015216-A1 Isoprenoid biosynthesis EISENREICH WOLFGANG 2007-01-18 US disclosed
US-7122331-B1 Isoprenoid biosynthesis EISENREICH WOLFGANG 2006-10-17 US disclosed
US-20060154349-A1 Production of coenzyme q-10 DSM IP ASSETS B.V. (NL) 2006-07-13 US disclosed
EP-1414838-A4 POLYPEPTIDES HAVING CAROTENOIDS ISOMERASE CATALYTIC ACTIVITY, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF YISSUM RES DEV CO (IL) 2005-12-14 EP disclosed
US-20050022269-A1 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2005-01-27 US disclosed
US-20040226502-A1 Crystal structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase BACHER, ADELBERT (DE) 2004-11-18 US disclosed
US-20040219656-A1 Novel antibacterial and herbicidal compounds and system for screening the same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-11-04 US disclosed
US-20040176570-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway ROHDICH, FELIX (DE) 2004-09-09 US disclosed
WO-2004072276-A1 CRYSTAL STRUCTURE OF 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE SYNTHASE IN COMPLEX WITH INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2004-08-26 WO disclosed
WO-2004072276-A1 CRYSTAL STRUCTURE OF 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE SYNTHASE IN COMPLEX WITH INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2004-08-26 WO disclosed
EP-1414838-A2 POLYPEPTIDES HAVING CAROTENOIDS ISOMERASE CATALYTIC ACTIVITY, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-05-06 EP disclosed
US-20040072142-A1 Non-mevalonate isoprenoid pathway BACHER ADELBERT (DE) 2004-04-15 US disclosed
EP-1377663-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY Bacher, Adelbert (DE) 2004-01-07 EP disclosed
EP-1287145-A2 THE NON-MEVALONATE ISOPRENOID PATHWAY Bacher, Adelbert (DE) 2003-03-05 EP disclosed
WO-2003008534-A2 POLYPEPTIDES HAVING CAROTENOIDS ISOMERASE CATALYTIC ACTIVITY, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2003-01-30 WO disclosed
WO-2002083720-A2 INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2002-10-24 WO disclosed
EP-1198575-A1 ISOPRENOID BIOSYNTHESIS Bacher, Adelbert (DE) 2002-04-24 EP disclosed
WO-2002031120-A1 SYSTEMS FOR SCREENING ANTIBACTERIAL AND HERBICIDAL COMPOUNDS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2002-04-18 WO disclosed
WO-2001094561-A2 THE NON-MEVALONATE ISOPRENOID PATHWAY BACHER ADELBERT (DE) 2001-12-13 WO disclosed
EP-1141379-A1 SCREENING FOR INHIBITORS OF TERPENOIDS BIOSYNTHESIS Bacher, Adelbert (DE) 2001-10-10 EP disclosed
WO-2001011055-A1 ISOPRENOID BIOSYNTHESIS BACHER ADELBERT (DE) 2001-02-15 WO disclosed
WO-2000036138-A1 SCREENING FOR INHIBITORS OF TERPENOIDS BIOSYNTHESIS BACHER ADELBERT (DE) 2000-06-22 WO disclosed
WO-2000036138-A1 SCREENING FOR INHIBITORS OF TERPENOIDS BIOSYNTHESIS BACHER ADELBERT (DE) 2000-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180110795-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PERIODONTAL DISEASE HMBS, AHCY, APOB PGD 704/4885MPI 565/4885PGK1 1601/4885
US-20040176570-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway FDPS, DHPS, COASY PGD 96/4885MPI 38/4885PGK1 598/4885
US-20180271098-A1 OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS CMPK1, IPMK, ITPA PGD 56/4885MPI 31/4885PGK1 239/4885
US-20160046651-A1 TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY IMPDH1, IMPDH2, SHMT2 PGD 36/4885MPI 10/4885PGK1 413/4885
US-20200345701-A1 USE OF STATINS IN OVERCOMING RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN BACTERIAL SPECIES SYNTHETIZING ISOPRENOIDS USING THE MEVALONATE SYNTHETIC PATHWAY COASY, HMGCR, SQLE PGD 341/4885MPI 803/4885PGK1 738/4885
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents CBR3, AOC3, AHR PGD 1146/4885MPI 3826/4885PGK1 3521/4885
US-20170136030-A1 TREATMENT OF MALARIA USING INHIBITORS OF THE ISPD ENZYME IN THE NON-MEVALONATE PATHWAY IMPDH1, IMPDH2, SHMT2 PGD 36/4885MPI 10/4885PGK1 413/4885
US-20080318227-A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway FDPS, DHPS, COASY PGD 83/4885MPI 35/4885PGK1 540/4885
US-20130130345-A1 PRODUCTION OF RENEWABLE AROMATIC COMPOUNDS AHR, ARNT, DDT PGD 739/4885MPI 2686/4885PGK1 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.